Growth impairment and growth hormone therapy in children treated for malignant brain tumours

European Journal of Pediatrics

Volumn 156, Issue 10, 1997, Pages 764-769

  Ilveskoski, I ^a   Saarinen, U M ^a   Wiklund, T ^a   Sipila I ^a   Makipernaa A ^b   Perkkio M ^c   Lanning, M ^d   Salmi, T T ^e   Pihko, H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

Author keywords

Brain tumours; Growth hormone therapy; Late effects; Radiotherapy

Indexed keywords

ADOLESCENT; ARTICLE; BODY GROWTH; BRAIN CANCER; BRAIN TUMOR; CHILD; FEMALE; FINLAND; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY HEIGHT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DWARFISM; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; MALE; PITUITARY-ADRENAL SYSTEM; RADIOTHERAPY, ADJUVANT;

EID: 0030771845     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050708     Document Type: Article

References (30)

1. Bengtsson BA, Brummer RJ, Bosaeus I (1990) Growth hormone and body composition. Horm Res 4: 19-24
2. Bercu B, Schulman D, Root A, Spiliotis B (1986) Growth hormone provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab 63: 709-716
3. Bleyer A, Millstein J, Balis F, et al (1983) Eight drugs in 1 day chemotherapy for brain tumours: a new approach and rationale for preradiation chemotherapy. Med Pediatr Oncol 11: 213 (Abstract)
4. Brauner R, Czedrnichow P, Rappaport R (1984) Precocious puberty after hypothalamic and pituitary irradiation in young children. N Engl J Med 311: 920
5. Brauner R, Rappaport R, Prevot C, et al (1989) A prospective study of the development of GH in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metab 68: 343-351
6. Clayton P, Shalet M (1991) Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr 118: 226-228
7. Clayton P, Shalet S, Gattamaneni H, Price D (1987) Does growth hormone cause relapse of brain tumors. Lancet 1: 711-713
8. Clayton P, Shalet S, Price D (1988) Growth response to growth hormone therapy following cranial irradiation. Eur J Pediatr 147: 593-596
9. Clayton P, Shalet S, Price D (1988) Growth response to growth hormone therapy following craniospinal irradiation. Eur J Pediatr 147: 597-601
10. Clayton PE, Shalet SM (1991) The evolution of spinal growth after irradiation. Clin Oncol R Coll Radiol 3: 220-2
11. Dixon W, Brown M, Engelman L, Hill M, Jennrich R (1993) ANOVA with repeated measures. BMDP Statistical Software Manual 496-502
12. Duffner P, Cohen M, Myers M, Heise H (1986) Survival of children with brain tumors. SEER Program, 1973-1980. Neurology 36: 597-601
13. Evans AE, Jenkin RD, Sposto R, et al (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72: 572-582
14. Hovi L, Saarinen U, Siimes M (1991) Growth failure in children after total body irradiation preparative for bone marrow transplantation. Bone Marrow Transplantation 8 [Suppl 1]: 10-13
15. Ilveskoski I, Saarinen U, Perkkiö M, et al (1996) Chemotherapy with the "8 in 1" protocol for malignant brain tumors in children: a population-based study in Finland. Pediatr Hematol Oncol 13: 69-80
16. Krischer JP, Ragab AH, Kun L, et al (1991) Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. J Neurosurg 74: 905-9
17. Lannering B, Marky I, Mellander R, Albertsson-Wikland K (1988) Growth hormone secretion and growth hormone therapy after treatment for brain tumor. Acta Peadiatr Scand [Suppl] 343: 146-151
18. Littley M, Shalet S, Beardwell C, Robinson E, Sutoon M (1989) Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinology 31: 363-373
19. Merriam G, Wachter K (1982) Algorithms for the study of episodic hormone secretion. Am J Physiol 243: 310-318
20. Miller RW, Young JJ, Novakovic B (1995) Childhood cancer. Cancer 75: 395-405
21. Moell C, Garwicz C, Westgren U, Wiebe T, Albertsson-Wikland K (1989) Suppressed spontaneous secretion of growth hormone in girls after treatment for acute lymphoblastic leukemia. Arch Dis Child 64: 252-258
22. Ogilvy-Stuart A, Shalet SM (1992) Tumour occurrence and recurrence. Horm Res 1: 50-55
23. Ogilvy-Stuart AL, Shalet SM (1995) Effect of chemotherapy on growth. Acta Paediatrica 84: 52-56
24. Olshan JS, Gubernick J, Packer RJ, et al (1992) The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 70: 2013-2017
25. Rappaport R, Brauner R (1989) Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 25: 561-567
26. Rosen T, Johannsson G, Johansson JO, Bengtsson BA (1995) Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper. Horm Res 43: 93-99
27. Rudman D, Feller A, Nagraj H . et al (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323: 1-6
28. Shalet S, Clayton P, Price D (1988) Growth impairment following treatment for childhood brain tumors. Acta Paediatr Scand [Suppl] 343: 137-145
29. Shalet S, Gibson B, Swindell R, Pearson D (1987) Effect of spinal irradiation on growth. Arch Dis Child 62: 461-464
30. Sposto R, Ertel I, Jenkin R, et al (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial. J Neuro-oncol 7: 165-177